U.S. Food and Drug Administration Senior Accountant Salaries in Wilmington, DE
The average U.S. Food and Drug Administration Senior Accountant in Wilmington, DE earns an estimated $94,416 annually, which includes an estimated base salary of $84,009 with a $10,407 bonus. U.S. Food and Drug Administration's Senior Accountant compensation is $6,077 more than the US average for a Senior Accountant. Senior Accountant salaries at U.S. Food and Drug Administration in Wilmington, DE can range from $49,920 - $185,000.
In Wilmington, DE, The Finance Department at U.S. Food and Drug Administration earns $14,133 more on average than the Admin Department.
Last updated 3 years ago.
- $84,009
- avg. base
- $10,407
- avg. bonus
Senior Accountant Salaries at U.S. Food and Drug Administration
In Wilmington, DE, Senior Accountants earn $1,871 more than Senior Accountants, and $1,756 less than Business Analysts.
Compensation at U.S. Food and Drug Administration by Department
In Wilmington, DE, The Finance Department averages $14,133 more than the Admin Department, and $10,567 less than the IT Department
Senior Accountant Compensation by Gender (All Companies)
The average female Senior Accountant at companies similar size to U.S. Food and Drug Administration reported making $84,874, while the average male Senior Accountant at similar sized companies reported making $97,131.
Senior Accountant Compensation by Ethnicity (All Companies)
The average Caucasian Senior Accountant at companies similar size to U.S. Food and Drug Administration reported making $91,995, while the average African American/Black Senior Accountant at similar sized companies reported making $66,666.
How Senior Accountants at U.S. Food and Drug Administration Rate Their Compensation
The majority of Senior Accountants at U.S. Food and Drug Administration believe they're compensated fairly. 100% of Senior Accountants at U.S. Food and Drug Administration say they receive annual bonuses, and the vast majority (71%) are satisfied with their benefits. See more compensation ratings at U.S. Food and Drug Administration
